Pharmacogenetics of catechol-O-methyltransferase: frequency of low activity allele in a Ghanaian population
- PMID: 11058906
- DOI: 10.1002/1098-1004(200011)16:5<445::AID-HUMU13>3.0.CO;2-3
Pharmacogenetics of catechol-O-methyltransferase: frequency of low activity allele in a Ghanaian population
Abstract
Catechol-O-methyltransferase (COMT) catalyses the O-methylation of neurotransmitters, catechol hormones and drugs such as levodopa and methyldopa. Ethnic differences in COMT activity have been observed in several populations. Previous studies suggest that the g1947G>A low activity allele is less common in individuals of African origin. COMT genotyping was performed using a mini-sequencing method in 195 healthy Ghanaians with a frequency of the homozygous g1947G>A of 6%. This study provides confirmation that the low activity COMT allele is less common in individuals of African origin. This finding may be important clinically with regards to the treatment of many neuropsychiatric disorders and in the pathophysiology of various human disorders including estrogen-induced cancers, Parkinson's disease, depression and hypertension.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.Acta Neurol Scand. 2004 Oct;110(4):260-6. doi: 10.1111/j.1600-0404.2004.00315.x. Acta Neurol Scand. 2004. PMID: 15355491
-
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2. Pharmacogenet Genomics. 2008. PMID: 18698234 Clinical Trial.
-
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.Mov Disord. 2005 Jun;20(6):734-9. doi: 10.1002/mds.20410. Mov Disord. 2005. PMID: 15747357 Clinical Trial.
-
Catechol-O-methyltransferase and Parkinson's disease.Acta Med Okayama. 2002 Feb;56(1):1-6. doi: 10.18926/AMO/31725. Acta Med Okayama. 2002. PMID: 11873938 Review.
-
Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.Pharmacol Rev. 1999 Dec;51(4):593-628. Pharmacol Rev. 1999. PMID: 10581325 Review. No abstract available.
Cited by
-
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.Neuropsychopharmacology. 2008 Dec;33(13):3078-84. doi: 10.1038/npp.2008.126. Epub 2008 Aug 13. Neuropsychopharmacology. 2008. PMID: 18704099 Free PMC article.
-
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.Mol Neurobiol. 2009 Jun;39(3):210-71. doi: 10.1007/s12035-009-8064-1. Epub 2009 Apr 17. Mol Neurobiol. 2009. PMID: 19373443 Review.
-
The promises and pitfalls of reboxetine.CNS Drug Rev. 2003 Winter;9(4):327-42. doi: 10.1111/j.1527-3458.2003.tb00258.x. CNS Drug Rev. 2003. PMID: 14647527 Free PMC article. Review.
-
Pharmacogenetics in Ghana: reviewing the evidence.Ghana Med J. 2011 Jun;45(2):73-80. doi: 10.4314/gmj.v45i2.68932. Ghana Med J. 2011. PMID: 21857725 Free PMC article.
-
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women.Pharmacogenet Genomics. 2005 Jun;15(6):393-8. doi: 10.1097/01213011-200506000-00004. Pharmacogenet Genomics. 2005. PMID: 15900212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous